News

Seven Things to Know About ProPublica’s Investigation of the FDA’s Secret Gamble on Generic Drugs
ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...
BioPharma Dive22h
Novo abruptly ends obesity drug deal with Hims
The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo ...
FDA Greenlights Twice-A-Year HIV Prevention Drug
Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...
ProPublica Sued the FDA for Withholding Records About the Safety of Generic Drugs
The agency declined to quickly release documents that would identify drugs made at some of the most troubled foreign ...
Gilead’s twice-a-year HIV prevention shot wins regulatory approval in US
Gilead Sciences Inc said it won United States approval from Food and Drug Administration regulators for a drug to prevent HIV that only has to be given twice a year. That makes it a convenient new way ...
US FDA extends review of KalVista's swelling disorder drug due to heavy workload
By Puyaan Singh (Reuters) -KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended ...
No Drug Price Pledges by Pfizer, Others in Talks With US Government, Pfizer CEO Says
(Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss most-favored-nation pricing but no commitments have been made, Chief Executive Albert Bourla said on Monday ...